Pharmaceutical Product Development, LLC (PPD) has expanded its vaccine sciences lab in Richmond, VA. The 17,000 sq.-ft. of new vaccines lab space significantly expands capacity for vaccine efficacy testing using techniques such as cell-based assays and immunochemistry.

PPD’s vaccine sciences lab provides services that support vaccine development, including method development, qualification and validation; statistical and regulatory; and high-throughput, automated and/or multiplex assays. The lab has experience with multiple assay formats, including molecular genomics, immunology, cell-based and functional assays.

“The recent expansion of our vaccine sciences lab, coupled with previous enhancements to our biologics capabilities, builds on three decades of drug development expertise to support pharmaceutical and vaccine programs from preclinical through post-approval,” said Bob Nicholson, senior vice president of PPD Laboratories. “During that time, we have helped our clients earn FDA approval for 15 vaccine programs and countless pharmaceuticals. We’re confident our laboratory enhancements will enable us to build on that record of success for our customers.”